Reduction of radiation exposure to patients in the follow-up of shockwave lithotripsy by Talati, J. (J.) et al.
Reduction of radiation exposure to patients in the follow-up
of shockwave lithotripsy
J . TALATI, S. KHAN, R. BIYABANI, R.A. KHAN, I . NAZ, F. ABBAS and N.-P. BUCHHOLZ
Urology Unit, Department of Surgery, The Aga Khan University, Karachi, Pakistan
Objectives To assess, in patients undergoing extracorpor-
eal shock wave lithotripsy (ESWL), if a policy of using
unilateral X-rays of the kidney, ureter and bladder
(hemi-KUB) whenever possible and appropriate
during diagnosis and follow-up, was successful in
reducing the radiation exposure associated with
ESWL.
Patients and methods Two groups of patients of
statistically comparable size and demography were
assessed retrospectively before and after the imple-
mentation of the policy. All had undergone ESWL for
radio-opaque upper urinary tract stones and all were
finally rendered stone-free. The number and type of all
radiological procedures from initial diagnosis of the
stone to documented stone-free status were recorded
and the dose calculated.
Results The appropriate use of hemi-KUB X-rays resulted
in a significant mean reduction of radiation exposure
after treatment of 2.28 mSv per patient (P<0.05).
Furthermore, as expected, the radiation dose was
clearly but not closely correlated with stone size
(r=0.419).
Conclusions The appropriate use of hemi-KUB X-rays
during the follow-up after ESWL is a simple and
effective way of significantly reducing the radiation
exposure of such patients.
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Introduction
Patients undergoing ESWL for urinary stone are exposed
to radiation in two ways. First, most lithotripters use X-
ray monitoring to locate the stone, and several studies
have examined such exposure [1–5]. Second, a far larger
dose of radiation is received by the patient before and
after ESWL, during the initial diagnosis of stone disease
and in the follow-up to monitor the success of therapy. To
our knowledge, there are no studies addressing this issue.
Besides natural background radiation, medical appli-
cations represent the second most intense source of
radiation exposure in humans [6]. An exposure of 1 mSv
is equivalent to 6 months natural background radiation,
but IVU causes a mean radiation exposure of 4.6 mSv to
the patient [7]. This radiation exposure has a risk of
somatic and genetic long-term complications [6,8–10].
Therefore, there is a unanimous demand to keep
radiation levels ‘as low as reasonably achievable’ [6].
Following these recommendations, a policy was
implemented in our institution in 1995 to minimize
the exposure to X-rays in the follow-up of patients who
underwent ESWL. Whenever adequate, a unilateral X-
ray of the kidney, ureter and bladder (hemi-KUB), or a
bladder X-ray only during the follow-up of a pre-vesical
stone, were to be used. This study determined whether
the implementation of the policy was efficient and if the
radiation exposure of the patient was reduced.
Patients and methods
The records of a representative group of consecutive
patients undergoing ESWL before (group 1) and after
(group 2) implementation of the policy were analysed
retrospectively. Group 1 included 78 patients (60 males
and 18 females, mean age 38.4 years, range 5–70)
treated between October 1994 and March 1995, and
group 2 comprised 67 patients (52 males and 15 females,
mean age 40.3 years, range 21–73) treated between
October 1995 and March 1996. All patients were treated
with the Dornier MPL 90001 (Dornier GmBh, Germany)
under continuous ultrasonographic guidance with the
patients lightly sedated. A mean of 4000 shock waves
were delivered at 14–20 kV. All patients had one or
several stones in either the kidney, PUJ or proximal
ureter. Patients were not selected for stone number, size
or type. Only those patients who were referred to and
followed up in our institution, and were stone-free after
ESWL, were included so that it was certain that all X-ray
exposure from diagnosis to stone-free status was recorded
accurately. Also recorded were the patient’s age and sex,
the location, size and number of the stone(s), and the
number and type of IVU and X-rays undergone before
and after ESWL in each patient. Patients who had bladderAccepted for publication 22 November 1999
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X-rays taken before ESWL were not considered. The
mean radiation dosages for the respective groups were
calculated according to published recommendations and
expressed as milliSeiverts (1 mSv=1 mJ/kg) [7]. Typical
doses are: for IVU, 4.6 mSv; full KUB X-ray, 1.5 mSv;
hemi-KUB X-ray, 0.75 mSv; and a bladder X-ray, 1.0
mSv.
The two groups were then compared for demographic
and radiation data. The correlation for all patients
between the stone surface area (SSA) and radiation
dose was calculated. Differences were assessed using
Student’s t-test, with P<0.05 considered to indicate a
significant difference.
Results
The characteristics of the stones in both groups are
shown in Table 1. Of the 78 patients in group 1, 70 (90%)
underwent IVU before ESWL; in three of the patients IVU
was necessary on two occasions. In those patients not
undergoing IVU, the stone was diagnosed by a combina-
tion of KUB X-ray and ultrasonography. Forty patients
(51%) needed an additional, confirmatory KUB X-ray
before ESWL. The mean total radiation dose per patient
before treatment is shown in Table 1. After treatment,
273 control KUB X-rays were taken in 77 patients; one
patient was assessed using ultrasonography alone. The
total mean radiation dose after treatment (from ESWL
until declared stone-free) is also shown in Table 1, with
the total radiation dose (from initial diagnosis, through
ESWL to stone-free status).
In group 2, 65 patients (97%) underwent IVU for
diagnosis; in one patient, an additional IVU was needed.
In addition, 24 patients needed 26 KUB-X-rays before
ESWL. The radiation doses before and after ESWL are also
given in Table 1. From ESWL to the last assessment
(confirmation of stone-free status), 49 patients still
underwent 109 full KUB X-rays. In addition, 65 hemi-
KUB X-rays were taken in 37 patients. There were no
significant differences in age, sex distribution, stone
localization, stone number, stones diameters and SSA (all
P>0.05) between the groups.
The radiation dose before ESWL was not significantly
different between the groups (P>0.05), but there were
significantly fewer full KUB X-rays and more hemi-KUB
X-rays (both P<0.05) in group 2. The dose after ESWL
and consequently the total radiation dose per patient
were both significantly reduced in group 2 (P<0.05),
with a mean reduction of 2.28 mSv/patient (Table 1).
There was a clear correlation between SSA and radiation
dose for all patients (r=0.419) (Fig. 1).
Discussion
There is continuing concern about the somatic and
genetic effects of radiation exposure in medicine; such
effects have not yet been fully measured in humans,
although animal studies indicate that they may occur
[6]. Especially in urogenital diagnostics and treatment,
radiation sensitive organs are either exposed or suffi-
ciently nearby to risk exposure [11]. The primary
concern about delayed somatic changes is radiation-
induced malignant disease [6]. The risk for fatal
radiation-induced cancer is estimated as the dose
equivalent (mSv)r0.0004 [9]. The individual medical
radiation exposure for the population in Germany was
Table 1 The characteristics of the stones and the radiation doses per patient before and after ESWL
Characteristic Group 1 Group 2
Stone location, n (%)
Kidney 39 (50) 36 (54)
PUJ 31 (39) 25 (37)
Proximal ureter 9 (11) 6 (9)
Right side 34 (43) 37 (55)
Mean (SD, range) stone size (mm)
Longitudinal diameter 12.6 (5.8, 2–33) 12.0 (6.2, 4–35)
Transverse diameter 8.8 (4.3, 2–20) 8.1 (4.3, 2–20)
SSA (mm2) 128 (113, 15–500) 118 (102, 8–525)
Patients, n (%), with
1 stone 66 (84) 61 (91.5)
2 stones 9 (11) 5 (7)
>2 stones 4 (5) 1 (1.5)
Mean (SD, range) radiation dose (mSv)
Before ESWL 5.38 (2.05, 0–12.2) 5.18 (1.32, 1.5–10.7)
After ESWL 5.78 (3.89, 0–18) 3.43 (2.12, 0–4)*
Total 11.09 (4.73, 3–27.2) 8.66 (2.43, 2.25–14.35)*
*P<0.05; SSA, stone surface area, LDrTD.
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estimated at 1–2 mSv/year, which would reduce the
mean life-span by 20–40 days. Although this mean value
seems negligible [8], the dose to individuals can be much
higher. Unnecessary medical radiation exposure is
believed to cause 100–250 cancer fatalities per year in
the UK alone [10].
Although radiation exposure and its possible reduction
during ESWL treatment have been evaluated previously
[1–5], to our knowledge there has been no attempt to
determine the mean radiation exposure of a patient
during diagnosis and assessment after stone fragmenta-
tion. The total mean dose during ESWL using an X-ray
monitored machine has been estimated at 0.75 mSv [4].
This corresponds to one hemi-KUB X-ray and seems
negligible. In contrast, most of the exposure occurs
during IVU and conventional radiography before and
after ESWL.
In the present study, the radiation dose during
treatment was not relevant, as the lithotripter used
ultrasonographic monitoring. Although patients were
limited to those with upper urinary tract stones (to
standardise the radiographs required) the patients were
not selected for stone type, number or size, or associated
variations in treatment. It was thus intended that the
patients were representative of those usually presenting
with stones, and comparable with patients in other parts
of the world [12]. In the present analysis, common
practice in radiation prevention was followed by using
standardized dose-equivalents per patient [6,7]; these are
known for most adult radiation procedures [13].
Most of the present patients underwent IVU before
ESWL; this is standard practice worldwide. Additional
KUB radiographs may be necessary, especially if there is
some delay before ESWL. As most stones can be assessed
after ESWL by X-ray, the patient’s exposure can only be
reduced by only exposing the affected side. The
implementation of this policy was successful; the
number of full KUB X-rays was reduced significantly
and replaced by hemi-KUB X-rays. This significantly
decreased the mean radiation exposure after ESWL by
2.28 mSv/patient, which corresponds to more than one
year’s mean medical radiation exposure [8], and to
14 months of natural background radiation. This
occurred despite the compliance of the prescribing
doctors being less than perfect; with increased compli-
ance the reduction could be greater. Radiation exposure
increases with stone burden during ESWL [3]; a larger
stone requires longer treatment, with possibly more
associated X-rays. This was confirmed by the correlation
between stone size and radiation dose for all patients.
Therefore, the implementation of a policy to reduce
conventional radiographic exposure by using limited-
exposure films was effective. It is a simple method to
reduce patient radiation exposure, with no loss of
information.
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Fig. 1. The correlation between stone
size and total radiation exposure in
patients undergoing ESWL (r=0.419).
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